/GBLP

GBLP Stock - Global Pharmatech, Inc.

Q: What is the analyst price target for GBLP?

Analyst price target information is not currently available for GBLP.

Q: What is GBLP's market cap?

Market capitalization information is not currently available for GBLP.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.05+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.06

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for GBLP

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2007

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.18

52W High$0.28

52W Low$0.05

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2007
Revenue	$310,895	$66,375	$58,585	N/A	$2.82M
Gross Profit	$34,655	$43,820	$29,397	N/A	$928,049
Gross Margin	11.1%	66.0%	50.2%	N/A	32.9%
Operating Income	$-67,815	$-139,575	$-21,800	$-113,280	$-2,491,880
Net Income	$-67,728	$-138,499	$-21,004	$-113,314	$-2,445,204
Net Margin	-21.8%	-208.7%	-35.9%	N/A	-86.7%
EPS	$-0.00	$-0.00	$-0.00	$-0.00	$-0.11

Company Overview

Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical medicine, traditional chinese medicine, and dietary supplements primarily in China. The company's principal product line consists of XS CAPSULE (XIN-SHU) for the treatment of angina and other coronary disease; JUTAI SOFT CAPSULE, a dietary supplement; QINGXUAN ANTI-HYPERTENSION TABLET, an over-the-counter drug product indicated for the treatment of hypertension and high serum cholesterol level; and YANREQING TABLET for the treatment of inflammation. It also manufactures and sells other proprietary drugs, generics, and dietary supplements used to treat symptoms ranging from headaches, coughing, and dry mouth to infections, and numbness of limbs. The company markets its products through distributors, such as wholesale companies and chain store representatives, as well as through its sales force. Global Pharmatech, Inc. was founded in 2001 and is based in Changchun, China.

Frequently Asked Questions about GBLP

What is GBLP's current stock price?

Global Pharmatech, Inc. (GBLP) is currently trading at $0.05 per share. The stock has moved +0.00% today.

What is the analyst price target for GBLP?

No analyst price targets are currently available for this stock.

What sector is Global Pharmatech, Inc. in?

Global Pharmatech, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is GBLP's market cap?

Global Pharmatech, Inc. has a market capitalization of $0.02 billion, making it a small-cap company.

Does GBLP pay dividends?

No, Global Pharmatech, Inc. does not currently pay a dividend to shareholders.